Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romuald Bellmann

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|January 3, 2013
Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosisRomuald Bellmann
Current Clinical Pharmacology|August 12, 2008
Clinical pharmacokinetics of systemically administered antimycoticsRomuald Bellmann
Current Clinical Pharmacology|February 9, 2013
Pharmacokinetic and pharmacodynamic considerations in the treatment of severe infectionsRomuald Bellmann
Journal of the American College of Cardiology|February 11, 2003
Patients with high-risk acute myocardial infarction randomized to one of two treatment strategies: delay and eligibility questionsChristoph Pechlaner, Romuald Bellmann
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|November 28, 2024
[Drug-drug interactions in critically ill patients]Romuald Bellmann, Stefan Weiler
The New England Journal of Medicine|May 25, 2007
Posaconazole prophylaxis in hematologic cancerStefan Weiler, Romuald Bellmann
JAMA|November 13, 2002
Thrombolytic therapy vs angioplasty in acute myocardial infarctionChristoph Pechlaner, Romuald Bellmann
Infection|July 14, 2017
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patientsRomuald Bellmann, Piotr Smuszkiewicz
Critical Care Medicine|January 21, 2006
Fluid management in acute lung injury--keep the lung dryJordan Kountchev, Romuald Bellmann, Michael Joannidis
Critical Care (London, England)|July 1, 2005
Between benzodiazepine over-sedation and neurological damageJordan Kountchev, Romuald Bellmann, Michael Joannidis
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|January 3, 2013
Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosisRomuald Bellmann
Current Clinical Pharmacology|August 12, 2008
Clinical pharmacokinetics of systemically administered antimycoticsRomuald Bellmann
Current Clinical Pharmacology|February 9, 2013
Pharmacokinetic and pharmacodynamic considerations in the treatment of severe infectionsRomuald Bellmann
Journal of the American College of Cardiology|February 11, 2003
Patients with high-risk acute myocardial infarction randomized to one of two treatment strategies: delay and eligibility questionsChristoph Pechlaner, Romuald Bellmann
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|November 28, 2024
[Drug-drug interactions in critically ill patients]Romuald Bellmann, Stefan Weiler
The New England Journal of Medicine|May 25, 2007
Posaconazole prophylaxis in hematologic cancerStefan Weiler, Romuald Bellmann
JAMA|November 13, 2002
Thrombolytic therapy vs angioplasty in acute myocardial infarctionChristoph Pechlaner, Romuald Bellmann
Infection|July 14, 2017
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patientsRomuald Bellmann, Piotr Smuszkiewicz
Critical Care Medicine|January 21, 2006
Fluid management in acute lung injury--keep the lung dryJordan Kountchev, Romuald Bellmann, Michael Joannidis
Critical Care (London, England)|July 1, 2005
Between benzodiazepine over-sedation and neurological damageJordan Kountchev, Romuald Bellmann, Michael Joannidis
Pageof 8